Network-based transcriptomic analysis reveals novel melatonin-sensitive genes in cardiovascular system
- 92 Downloads
Heart disease is a major cause of mortality and disability worldwide. Melatonin is a neuroendocrine hormone and has been found to be protective in heart disease. However, the molecular basis underlying this cardioprotective effect is not fully understood. Here we aim to investigate melatonin-sensitive genes in cardiovascular system using public gene expression databases.
An innovative genomic analysis method, the weighted gene co-expression network analysis (WGCNA) combined with differential gene expression analysis, was used in this study. The algorithm was implemented in R/Bioconductor.
Using this method, we provide a comprehensive characterization of transcriptional profiles associated with melatonin treatment. We found that 357 differentially expressed genes (DEGs) were highly sensitive to melatonin in mouse myocardium. Enrichment analysis showed that these 357 genes were mostly related to GO:0051984 (positive regulation of chromosome segregation), GO:0016605 (PML body) and GO:0006281 (DNA repair). We further obtained 5 hub genes from the 357 DEGs, including Set, Dhx40, Scaf11, Cfh, and Nup43.
We identified numerous melatonin-sensitive genes and further identified five hub genes. The five novel genes are possibly associated with the myocardial benefits of melatonin.
KeywordsMelatonin Transcriptomic analysis Network pharmacology WGCNA
We thank the Tongji Medical Science Library for computer resources. We thank our collaborators at the Department of Pathophysiology at Huazhong University of Science and Technology for their assistance in the study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This article does not contain any studies with animals performed by any of the authors.
- 7.I. Loiodice, A. Alves, G. Rabut, M. Van Overbeek, J. Ellenberg, J.B. Sibarita, V. Doye, The entire Nup107-160 complex, including three new members, is targeted as one entity to kinetochores in mitosis. Mol. Biol. Cell 15(7), 3333–44 (2004). https://doi.org/10.1091/mbc.e03-12-0878 CrossRefGoogle Scholar
- 8.G.T. Haskell, B.C. Jensen, L.A. Samsa, D. Marchuk, W. Huang, C. Skrzynia, C. Tilley, B.A. Seifert, E.A. Rivera-Munoz, B. Koller, K.C. Wilhelmsen, J. Liu, H. Alhosaini, K.E. Weck, J.P. Evans, J.S. Berg, Whole exome sequencing identifies truncating variants in nuclear envelope genes in patients with cardiovascular disease. Circ. Cardiovasc. Genet. 10(3) (2017). https://doi.org/10.1161/CIRCGENETICS.116.001443
- 12.S.A. Rosales-Corral, D. Acuna-Castroviejo, A. Coto-Montes, J.A. Boga, L.C. Manchester, L. Fuentes-Broto, A. Korkmaz, S. Ma, D.X. Tan, R.J. Reiter, Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin. J. Pineal Res. 52(2), 167–202 (2012). https://doi.org/10.1111/j.1600-079X.2011.00937.x CrossRefGoogle Scholar
- 14.T.B. Lin, M.C. Hsieh, C.Y. Lai, J.K. Cheng, H.H. Wang, Y.P. Chau, G.D. Chen, H.Y. Peng, Melatonin relieves neuropathic allodynia through spinal MT2-enhanced PP2Ac and downstream HDAC4 shuttling-dependent epigenetic modification of hmgb1 transcription. J. Pineal Res. 60(3), 263–76 (2016). https://doi.org/10.1111/jpi.12307 CrossRefGoogle Scholar
- 15.K.C. Koeijvoets, S.P. Mooijaart, G.M. Dallinga-Thie, J.C. Defesche, E.W. Steyerberg, R.G. Westendorp, J.J. Kastelein, P.M. van Hagen, E.J. Sijbrands, Complement factor H Y402H decreases cardiovascular disease risk in patients with familial hypercholesterolaemia. Eur. Heart J. 30(5), 618–23 (2009). https://doi.org/10.1093/eurheartj/ehn568 CrossRefGoogle Scholar
- 21.J.X. Jin, S. Lee, A. Taweechaipaisankul, G.A. Kim, B.C. Lee, Melatonin regulates lipid metabolism in porcine oocytes. J. Pineal Res. 62(2) (2017). https://doi.org/10.1111/jpi.12388
- 22.B. Zhang, S. Horvath, A general framework for weighted gene co-expression network analysis. Stat. Appl. Genet. Mol. Biol. 4, Article 17 (2005). https://doi.org/10.2202/1544-6115.1128